About Envoy Medical, Inc.
https://www.envoymedical.comEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004.
CEO
Brent T. Lucas
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ATLAS MERCHANT CAPITAL LLC
Shares:555.53K
Value:$372.87K
VANGUARD GROUP INC
Shares:339.11K
Value:$227.61K
WEISS ASSET MANAGEMENT LP
Shares:242.64K
Value:$162.86K
Summary
Showing Top 3 of 32
About Envoy Medical, Inc.
https://www.envoymedical.comEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $42K ▼ | $5.55M ▲ | $-6.48M ▼ | -15.43K% ▼ | $-0.35 ▼ | $-5.93M ▼ |
| Q2-2025 | $78K ▲ | $4.91M ▼ | $-5.69M ▼ | -7.29K% ▲ | $-0.32 ▼ | $-4.98M ▼ |
| Q1-2025 | $46K ▲ | $4.93M ▲ | $-5M ▼ | -10.87K% ▲ | $-0.29 ▲ | $-4.44M ▼ |
| Q4-2024 | $42K ▼ | $4.41M ▼ | $-4.62M ▲ | -11K% ▼ | $-0.36 ▲ | $-4.19M ▲ |
| Q3-2024 | $56K | $4.84M | $-5.96M | -10.64K% | $-0.37 | $-5.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.56M ▼ | $8.18M ▼ | $15.71M ▼ | $-7.53M ▲ |
| Q2-2025 | $5.29M ▼ | $9.9M ▼ | $39.76M ▲ | $-29.86M ▼ |
| Q1-2025 | $5.31M ▼ | $10.38M ▼ | $34.61M ▲ | $-24.22M ▼ |
| Q4-2024 | $5.48M ▲ | $11.54M ▲ | $30.38M ▲ | $-18.84M ▼ |
| Q3-2024 | $4.42M | $9.4M | $27.93M | $-18.53M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.48M ▼ | $-4.33M ▲ | $0 ▲ | $2.6M ▼ | $-1.73M ▼ | $-4.33M ▲ |
| Q2-2025 | $-5.69M ▼ | $-4.46M ▼ | $-1K ▲ | $4.44M ▲ | $-25K ▲ | $-4.46M ▼ |
| Q1-2025 | $-5M ▲ | $-3.73M ▲ | $-6K ▼ | $3.55M ▼ | $-171K ▼ | $-3.73M ▲ |
| Q4-2024 | $-6.28M ▼ | $-4.39M ▼ | $534K ▲ | $4.91M ▼ | $1.06M ▼ | $-3.85M ▼ |
| Q3-2024 | $-5.96M | $-2.81M | $-615K | $6.1M | $2.68M | $-3.42M |
CEO
Brent T. Lucas
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 2 of 12
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
ATLAS MERCHANT CAPITAL LLC
Shares:555.53K
Value:$372.87K
VANGUARD GROUP INC
Shares:339.11K
Value:$227.61K
WEISS ASSET MANAGEMENT LP
Shares:242.64K
Value:$162.86K
Summary
Showing Top 3 of 32